0.7003USD-4.20%Mkt Cap: 55.55M USDP/E: —Last update: 2026-05-26
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the…
Industry Peers
Drug Manufacturers - Specialty & Generic152.45BSEKP/E 166.3
58.11BTRYP/E 27.8
55.80BEURP/E 22.1
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BEURP/E 30.3
Indicators:|
Key Statistics
Company
Market Cap55.55M USD
Enterprise Value-797.73K USD
Revenue (TTM)20.34M USD
Gross Profit20.34M USD
Net Income (TTM)-8.61M USD
Revenue/Share0.4040 USD
Last Price0.7003 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees18
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS8112922005
Valuation
P/E (Trailing)—
P/E (Forward)-2.25
PEG—
EV/EBITDA—
EV/Revenue-0.04
P/S2.77
P/B1.07
EPS (TTM)-0.48
EPS (Forward)-0.32
52W Range
0.565018% of range1.310
52W High1.310 USD
52W Low0.5650 USD
Profitability
Gross Margin100.00%
Oper. Margin-119.95%
EBITDA Margin0.00%
Profit Margin-41.79%
ROE-17.44%
ROA-14.58%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.28M USD
CapEx (TTM)—
FCF Margin13.03%
FCF Yield4.77%
Net Debt-57.20M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.04
Current Ratio3.94
Quick Ratio3.73
Book Value/Sh0.6660 USD
Cash/Share0.7460 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 17, 2020
Splits
Last Split1:10
Split DateJul 17, 2020
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)4.193 USD
Target Range3.000 USD – 5.580 USD
# Analysts3
Ownership
Shares Out.79.44M
Float57.60M
Insiders1.96%
Institutions42.33%
Short Interest
Short Ratio2.2d
Short % Float2.69%
Short % Out.2.64%
Shares Short2.10M
Short (prev mo.)1.22M
Technical
SMA 500.9140 (-23.4%)
SMA 2000.8013 (-12.6%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)396.64K
Avg Vol (10d)401.66K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—